The case-series studies identified chest pain as the most common cardiovascular symptom among long-COVID patients (22%), ...

Patients recorded their vital signs thrice daily ... fluoxetine's weak antiviral activity in adults with early symptomatic COVID-19. There were no significant differences in the time to symptom ...

They analysed signs of inflammation ... the study found those who developed Covid-19 early in the pandemic had double the risk for cardiovascular events, while those with severe cases had nearly ...

Life After the Pandemic," we're showcasing how Omaha's medical field handled the pandemic and what they learned.

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox.

With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial ... progress quickly and it's key to catch complications early, before they become life-threatening." ...

People seem to pass on the virus most often about two days before symptoms show up and during the early stages ... positive for the coronavirus. Not all of these animals had signs of illness ...

President Donald Trump signed an executive order withdrawing the US from the WHO, citing mishandling of the COVID-19 pandemic and financial disparities ... He accused the WHO of mishandling the early ...

“Some cases are so mild that people would not even think about testing themselves” for COVID-19. Deaths from the virus have been on the decline since early 2022 after a massive spike in cases ...

shows that this increase in mortality was not just a short-term effect of COVID-19 but rather part of a longer trend that began around 2010. If death rates had continued at pre-2010 levels, early ...

Adam Remmer, Charge Nurse, South Tyneside and Sunderland NHS Foundation Trust. Background of change and intervention Before the pandemic, services in South Tyneside and Sunderland were already ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...